Guardian Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Sell
7,300
-250
-3% -$14.4K 0.27% 48
2026
Q1
$458K Sell
7,550
-450
-6% -$26.2K 0.36% 47
2025
Q4
$432K Sell
8,000
-1,500
-16% -$72.2K 0.34% 49
2025
Q3
$428K Hold
9,500
0.36% 49
2025
Q2
$440K Sell
9,500
-350
-4% -$17.2K 0.44% 43
2025
Q1
$601K Sell
9,850
-1,500
-13% -$87.4K 0.51% 44
2024
Q4
$642K Hold
11,350
0.46% 44
2024
Q3
$587K Sell
11,350
-600
-5% -$28.1K 0.51% 46
2024
Q2
$496K Sell
11,950
-2,175
-15% -$97.3K 0.36% 50
2024
Q1
$766K Sell
14,125
-10,700
-43% -$545K 0.62% 44
2023
Q4
$1.27M Sell
24,825
-11,043
-31% -$580K 1.07% 31
2023
Q3
$2.08M Buy
35,868
+200
+0.6% +$12.3K 1.89% 18
2023
Q2
$2.29M Sell
35,668
-9,278
-21% -$622K 1.95% 18
2023
Q1
$2.84M Buy
44,946
+5,696
+15% +$402K 2.13% 18
2022
Q4
$2.82M Sell
39,250
-500
-1% -$37.7K 2.67% 13
2022
Q3
$2.83M Sell
39,750
-1,000
-2% -$72.5K 2.86% 8
2022
Q2
$3.14M Hold
40,750
2.73% 8
2022
Q1
$2.98M Hold
40,750
2.31% 14
2021
Q4
$2.54M Sell
40,750
-700
-2% -$41.1K 1.77% 24
2021
Q3
$2.45M Sell
41,450
-10,996
-21% -$724K 1.81% 21
2021
Q2
$3.5M Buy
52,446
+7,500
+17% +$489K 2.4% 13
2021
Q1
$2.84M Sell
44,946
-275
-0.6% -$17.1K 2.01% 20
2020
Q4
$2.81M Sell
45,221
-300
-0.7% -$18.4K 2.13% 15
2020
Q3
$2.74M Sell
45,521
-1,500
-3% -$90.3K 2.39% 15
2020
Q2
$2.76M Sell
47,021
-343
-0.7% -$20.5K 2.51% 13
2020
Q1
$2.64M Buy
47,364
+2,500
+6% +$153K 2.7% 11
2019
Q4
$2.88M Sell
44,864
-1,400
-3% -$80.2K 2.29% 15
2019
Q3
$2.35M Buy
46,264
+3,510
+8% +$165K 2.08% 16
2019
Q2
$1.94M Buy
42,754
+500
+1% +$23.3K 1.69% 23
2019
Q1
$2.02M Sell
42,254
-3,040
-7% -$151K 1.75% 20
2018
Q4
$2.35M Buy
45,294
+890
+2% +$47.8K 2.17% 19
2018
Q3
$2.76M Sell
44,404
-1,674
-4% -$99.3K 2.43% 16
2018
Q2
$2.55M Buy
46,078
+6,501
+16% +$351K 2.44% 15
2018
Q1
$2.5M Sell
39,577
-689
-2% -$44.3K 2.67% 15
2017
Q4
$2.47M Buy
40,266
+151
+0.4% +$9.45K 2.6% 16
2017
Q3
$2.56M Buy
40,115
+1,000
+3% +$58.4K 2.82% 15
2017
Q2
$2.18M Sell
39,115
-1,750
-4% -$95.2K 2.41% 16
2017
Q1
$2.22M Buy
40,865
+4,900
+14% +$269K 2.42% 14
2016
Q4
$2.1M Buy
35,965
+525
+1% +$28.7K 2.43% 14
2016
Q3
$2.61M Hold
35,440
2.9% 10
2016
Q2
$2.61M Sell
35,440
-2,383
-6% -$168K 2.9% 10
2016
Q1
$2.42M Sell
37,823
-3,000
-7% -$189K 2.77% 12
2015
Q4
$2.81M Sell
40,823
-3,400
-8% -$225K 3.01% 9
2015
Q3
$2.93M Sell
44,223
-1,777
-4% -$113K 3.25% 8
2015
Q2
$3.11M Sell
46,000
-6,000
-12% -$395K 3.47% 8
2015
Q1
$3.32M Hold
52,000
3.69% 7
2014
Q4
$3.07M Hold
52,000
3.23% 9
2014
Q3
$2.69M Hold
52,000
3.11% 9
2014
Q2
$2.52M Hold
52,000
2.75% 10
2014
Q1
$2.69M Hold
52,000
3.11% 9
2013
Q4
$2.78M Buy
52,000
+3,070
+6% +$156K 3.08% 7
2013
Q3
$2.26M Hold
48,930
3.08% 9
2013
Q2
$2.21M Buy
+48,930
New +$2.12M 3.19% 8

Other funds holding BMY

Guardian Investment Management's BMY Position: Q2 2026 in Review

Guardian Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, selling an estimated $14.4K and leaving 7,300 shares worth $421K. The position accounts for 0.27% of the portfolio, ranked #48.

Guardian Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.5M in Q2 2021. 979 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Guardian Investment Management held 7,300 shares of Bristol-Myers Squibb worth $421K as of Q2 2026.
  • Guardian Investment Management sold 250 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.4K.
  • Bristol-Myers Squibb made up 0.27% of Guardian Investment Management's portfolio in Q2 2026, its #48 holding.
  • Guardian Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Guardian Investment Management's Bristol-Myers Squibb position peaked at $3.5M in Q2 2021.
  • 979 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.